welcomes you to the new, improved website!LVR using endobronchial therapies remains experimental. This multicenter study tested LVR coils in 60 pts for safety and efficacy. There were a total of 18 serious adverse events. At 6 and 12 mos, dyspnea scores decreased 11%, 6 min walk increased 30-50 m, and FEV1 increased 0.11 L. Pts with either heterogeneous or homogeneous emphysema appeared to improve.
You are here:
Lung volume reduction coil treatment for patients with severe emphysema: a European multicentre trial
Submitted by: Mark Ferguson
Source: Thorax
Keywords:
Author(s): Gaëtan Deslee, Karin Klooster, Martin Hetzel, Franz Stanzel, Romain Kessler, Charles-Hugo Marquette, Christian Witt, Stefan Blaas, Wolfgang Gesierich, Felix J F Herth, Juergen Hetzel, Eva M van Rikxoort, Dirk-Jan Slebos
